Navigation Links
Cancer screening: The efficacy of mammography screening
Date:12/3/2012

How effective is the German mammography screening program? This is the question examined by Oliver Heidinger of the Epidemiological Cancer Registry North RhineWestphalia and his co-authors in the first study on this subject in Germany, in Deutsches rzteblatt International (Dtsch Arztebl Int 2012; 109(46): 781-7).

To answer it, the authors have used the interval cancer rate as an indicator. Interval cancers are tumors found more or less by chance between two screenings. In approximately 880 000 women from North RhineWestphalia who had taken part in mammography screening for the first time between 2005 and 2008 and had received negative test results, the authors examined whether breast cancer occurred in the following 24 months. It was shown to occur in approximately 2000 women. This corresponds to a rate of 0.23%, a result that is absolutely comparable with similar international studies.

However, the authors also noticed another result in their follow-up research: 40% of all malignant breast tumors of size T2 to T4 (i.e. ranging from at least 2 cm to more than 5 cm) detected in the study participants during the observation period proved to be interval cancers. Further research is needed to explain this phenomenon.


'/>"/>

Contact: Oliver Heidinger
Oliver.Heidinger@krebsregister.nrw.de
Deutsches Aerzteblatt International
Source:Eurekalert

Page: 1

Related medicine news :

1. Clinical trial at GHSU Cancer Center targets advanced prostate cancer
2. New DNA-Based Blood Test May Spot Signs of Cancer
3. Aspirin May Reduce Risk of Liver Cancer, Death From Liver Disease
4. Johns Hopkins scientists pair blood test and gene sequencing to detect cancer
5. COUP-TFII sparks prostate cancer progression
6. Studies from 2012 Quality Care Symposium highlight findings in improving quality of cancer care
7. Researchers report first success of targeted therapy in most common non-small cell lung cancer
8. Scripps Florida scientists uncover a novel cooperative effort to stop cancer spread
9. Research from ASCOS Quality Care Symposium shows advances and challenges in improving the quality of cancer care
10. Scripps Research Institute study points to potential new therapies for cancer and other diseases
11. Study: Chest CT Scans May Increase Breast Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol ... is introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex ... in horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the ...
(Date:4/24/2017)... ... April 24, 2017 , ... Michael Vick announced his retirement earlier this ... The former overall number one pick in the 2001 NFL Draft, to the Atlanta ... record for the most career rushing yards by a quarterback (6,109) and the most ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director Kevin Welner ... Education Research Award. The award honors scholars exemplary in their capacity to communicate ... who has demonstrated the capacity to deepen the public’s understanding and appreciation of ...
(Date:4/24/2017)... ... April 24, 2017 , ... Sean Fay is the undisputed ... Sonicare Toothbrush, Juiceman Juicer, and the George Foreman Grill (which sold more than 100 ... in the last 25 years. , Now, due to changes in the broadcast media ...
(Date:4/24/2017)... ... April 24, 2017 , ... The world-class designers ... to bring their novel lifesaving device for the everyday use of parents worldwide. ... specially designed to read a child’s vital signs, and detect unusual symptoms or ...
Breaking Medicine News(10 mins):
(Date:4/21/2017)... 2017 Halo Labs announces the launch of ... system called the Horizon at PEGS 2017 in ... system analyzes sub visible particulate matter in biopharmaceutical samples ... as early as candidate selection and pre-formulation. ... research organization Elion Labs for system validation. ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... the "Global Biosimilar Pipeline and Market Prospects: Addressing ... report to their offering. ... "Global Biosimilar Pipeline and Market ... by Design" provides an in-depth assessment of the current ...
(Date:4/20/2017)... 20, 2017   ZappRx, Inc ., a digital health ... process, today announced it closed $25 million in Series B ... firm based in Seattle that is ... . The Series B round included participation from SR ... and GV (formerly Google Ventures). As part of ...
Breaking Medicine Technology: